Cannabis and Hemp Industry Investment News
Nic's Beverages CEO John Goodpasture says DehydraTECH technology is 'perfect' for allowing the delivery of CBD from hemp oil with 'zero impact' on the...
Lexaria's DehydraTECH technology can be applied to foods, beverages, oral suspensions, tablets and capsules Cannabis stocks were faced with yet anothe...
What are you searching for? viewLexaria Bioscience Corp. The company will help Lexaria with investor presentations, articles and videos, and other dig...
What are you searching for? viewLexaria Bioscience Corp. Shareholders approved all matters at the annual general meeting, including the appointment of...
What are you searching for? viewLexaria Bioscience Corp. () (OTCMKTS:LXRP) CEO Chris Bunka tells Proactive Investors a new version of the Kelowna, Bri...
New enhanced DehydraTECH formulation delivers 8X more CBD into blood and over 19X more CBD into brain tissue than standard formulations The Kelowna, B...
The Canadian company has developed the science to combine DehydraTECH with nanoemulsification for specific performance applications The Kelowna, Briti...
Over the next two years, 1906 is expanding its premium edibles, which combine cannabis and plant medicines, to key legal markets including Illinois, O...
The company’s formulation delivered 475% more CBD to the bloodstream in 15 minutes than other standard industry formulations The Kelowna-headquartered...
What are you searching for? viewLexaria Bioscience Corp. The company is pairing its DehydraTECH system with a Nevada-based private company The Kelowna...
The Kelowna-headquartered company has developed and out-licenses its disruptive DehydraTECH technology Lexaria has expanded its advisory board () (OTC...
The company said the five-year definitive agreement will provide its Dehydratech technology to a private California-based cannabis company for use in ...
What are you searching for? viewLexaria Bioscience Corp. The new contracts last for three years and will allow the company to make sure its senior tea...
This project is testing for a variety of potential performance-enhancing variations of the company's DehydraTECH delivery technology DehydraTECH can b...
FDA Commissioner Scott Gottlieb said nicotine replacement therapy is 'generally considered to double the likelihood of a successful quit attempt' The ...
What are you searching for? viewLexaria Bioscience Corp. Lexaria Bioscience (CSE:LXX-OTCQX:LXRP) President John Docherty joined Steve Darling from Pro...
A single 90mg dose of TurboCBD showed evidence of lower blood pressure and higher blood flow to the brain Lexaria intends to conduct further clinical ...
What are you searching for? viewLexaria Bioscience Corp. Lexaria Bioscience (CSE:LXX-OTCQX:LXRP) CEO Chris Bunka joined Steve Darling from Proactive I...
Shares of Lexaria jumped after the announcement, which will fund research on oral forms of nicotine delivery, using Lexaria's DehydraTECH technology A...
What are you searching for? viewLexaria Bioscience Corp. Separately, the company has appointed Dr Ed Ergenzinger as chief legal officer and senior vic...
